Tokyo, April 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061236) titled 'Multicenter repeated point prevalence study of the recognition gap of delirium in hospitalized non-cancer patients' on April 13.

Study Type: Observational

Primary Sponsor: Institute - Osaka Rosai Hospital

Condition: Condition - Delirium in hospitalized patients with non-cancer progressive life-limiting illnesses Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Delirium is a common and clinically important syndrome among hospitalized patients, and failure to recognize it may lead to inappropriate management and poorer outcomes. However, in hospitalized patients with non-cancer progressive life-limiting illnesses, the gap between delirium detected by a standardized tool and delirium recognized and documented by the clinical team has not been sufficiently studied. This multicenter study aims to estimate the proportion of delirium cases identified by trained raters using the 4AT on the same day that are also recognized and documented as delirium by physicians or nurses in the medical record. In addition, the study will explore point prevalence of delirium, associations of recognition status with outcomes and interventions, and inter-facility variation. Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Hospitalized patients meeting all of the following criteria will be included:

Admitted to a general ward of a participating institution. Have a non-cancer progressive life-limiting illness. Present in the ward on the study assessment day. Judged eligible according to the operational criteria predefined in the study protocol. Delirium assessment can be performed, or the reason for non-availability can be recorded. Key exclusion criteria - 1) Patients managed in the ICU or HCU 2) Patients who declined participation through the opt-out process 3) Patients for whom even minimal required data collection is not feasible on the study day 4) Patients considered inappropriate for inclusion by the principal investigator or subinvestigators Target Size - 1000

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 02 Month 04 Day Anticipated trial start date - 2026 Year 06 Month 01 Day Last follow-up date - 2026 Year 11 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070069

Disclaimer: Curated by HT Syndication.